BWX TECHNOLOGIES, INC. (BWXT): what the price assumes

In the published model solve dated 2026-Q2, anchored at $152.85, BWX TECHNOLOGIES, INC. (BWXT) is priced for today's economics sustained for ~5.8 years. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-07-25.

Generated: 2026-08-30 · Source: https://boothcheck.com/report/BWXT

Headline

FieldValue
TickerBWXT
CompanyBWX TECHNOLOGIES, INC.
Sector / IndustryIndustrials
Current price$152.85/sh
CompositionGovernment Operations 73% / Commercial Operations 27% / Eliminations 0%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin (value-band context)5.7%
Operating margin today12.3%
Margin compression (value-band)-6.6pp
Must persist for5.8y
Multiple paid37x operating income

The operating-margin figure is value-band context at year 12: derived from the framework's value band, a separate calculation — not part of the priced-in solve.

Solve inputs: computed at a 8.3% cost of capital; growth searched up to the 25% self-funding ceiling.

How unusual the bet is: elevated (limited comparison data)

ReferenceValue
vs own history+0.16σ
cohort percentile (of 225 peers)89

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset3.13x4expensive
Earnings5.89x5expensive
Relative1.78x2expensive
Growth0.76x3justifies

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.1%); the inversion above states its own rate.

Per-Model Detail (n=14)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$231.830.66xyesFCF base $0.5B, growth 21% (input: historical growth), terminal g 4.0%, WACC 8.1%, 7yr projection
DCF Exit MultipleGrowth$202.100.76xyesExit EV/EBITDA: 33.0x / 35.0x / 37.0x (bear / base = today's held flat / bull), 7yr
Relative ValuationRelativenoP/E 24.79x (blended: static sector reference 18x + trailing (TTM) 41x), scenarios: 20.1x / 24.8x / 29.5x (bear / base = reference held flat / bull), EV/EBITDA 18.89x
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$40.663.76xyesBV/sh $13.98, ROE (TTM) 26.9%, ke 9.3%
Two-Stage Excess ReturnAsset$70.332.17xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$173.600.88xyesRev $3.4B, growth 21% (input: historical growth; tapered), Terminal P/S: 3.4x / 4.1x / 4.9x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$71.622.13xyesEPS $3.74, growth 19% (input: historical EPS growth), PEG=2.12 (Overvalued)
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$25.975.89xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.38B × (1−15%) / WACC 8.1% → EPV (no growth)
Residual IncomeAsset$60.902.51xyesBV $13.98 + 5yr PV of (ROE (TTM) 26.9% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAsset$34.304.46xyes√(22.5 × EPS $3.74 × BVPS $13.98) — Graham's conservative floor
EV/EBITDA RelativeRelativenoEBITDA $0.44B × sector EV/EBITDA 12.0x
FCF YieldEarnings$22.286.86xyesFCF $328.1M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$18.568.24xyesSBC-adj FCF $0.30B (FCF $0.33B − SBC $0.03B) capitalized at Kₑ
Ben Graham FormulaEarnings$120.681.27xyesEPS $3.74 × (8.5 + 2×15.0%) × (4.4 / 5.3%)
ROIC-Justified P/BAsset$5.6127.25xyesBV $13.98 × (ROIC 3.3% / WACC 8.1%) (excluded from median)
P/Sales SectorRelativenoRevenue $3.38B × sector P/S 2.5x
PEG Fair ValueRelative$107.431.42xyesEPS $3.74 × (PEG 1.5 × growth 19.2% (input: historical EPS growth)) → PE 28.7x
Earnings YieldEarnings$40.433.78xyesEPS $3.74 / required return 9.3% (Rf 4.3% + ERP 5.0%)
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Government Operationsoperatingenterprise$2.4b$394.9m operating-incomewithheldunresolved no unit value
Commercial Operationsoperatingenterprise$853.1m$57.7m operating-incomewithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$1.5b
Net debt / NOPAT (after-tax)4.27x
Net debt / operating income (pre-tax)3.63x
Interest coverage10.1x
Share count CAGR (dilution)0.0%
Burning cashno

Bullet Takeaways

Bull Case

Sort the valuation methods by what each one can actually see and the disagreement over this company stops being confusing. The approaches that work from book value and last year's earnings land far under the current quote, because what they measure is a manufacturer with a few billion dollars of revenue and a modest asset base. Only the forward cash-flow methods reach the price, and they reach past it. The difference between the two groups is not optimism. It is time horizon, and BWXT's business happens to be one where the time horizon is written down: the order book was $7,260.7 million on December 31, 2025, and the company expects to recognize roughly 40% of that revenue by the end of 2026, with the rest arriving after. Most of the value being argued about sits in years the backward-looking methods structurally cannot reach.

The reason that book is durable is regulatory rather than commercial. Through Government Operations, the 10-K states, the company engineers, designs and manufactures "precision naval nuclear components, reactors and nuclear fuel for the U.S. Department of Energy ("DOE")/National Nuclear Security Administration's ("NNSA") Naval Nuclear" program. The barriers to entering that work are described in the same filing: "significant portions of the designs, processing and final product are classified by the U.S. Government, requiring applicable personnel to obtain and maintain U.S. Government security clearances", alongside high regulatory licensing costs. A competitor cannot decide to enter this market next year. It would need cleared people, licensed facilities and a decade of qualification, and the customer would have to want a second supplier badly enough to fund it.

The faster-moving half of the story is commercial. First-quarter 2026 revenue in Commercial Operations was $283.6 million against $128.3 million a year earlier, and segment operating income went from $6.5 million to $24.0 million, driven by commercial nuclear components, field services, fuel and fuel handling, medical sales and the contribution from Kinectrics. In the same quarter the company announced the acquisition of Precision Components Group, described as its first step in establishing U.S.-based commercial nuclear manufacturing capacity. A business that already knows how to build reactor components to naval standards is unusually well placed when a civilian nuclear buildout needs domestic suppliers.

Set against the defense primes it competes with for capital, the profitability comparison is the quiet argument. BWXT's trailing operating margin is 12.3%. LDOS earns 12.0% on $17.33 billion of revenue with sales up 2.3% on the year; NOC earns 11.6% on $42.37 billion with growth of 5.0%; GD 10.2% on $53.81 billion with 9.3%; LMT 9.9% on $75.11 billion with 4.6%. BWXT matches the margin of the best-run large primes while growing several times faster than any of them. That combination is what the price is paying for, and it is not a common one in this industry.

Bear Case

The variable with the most leverage over this thesis is an appropriations bill, and the 10-K opens its risk factors there: "We rely on U.S. Government contracts (either directly or as a sub-tier contractor to a government contractor) for a substantial percentage of our revenue, and some of those contracts are subject to continued appropriations by Congress and may be terminated or delayed if future funding is not made" available. Government Operations is 73% of revenue. And the exposure is quantified inside the order book itself: of the $7,260.7 million of backlog at December 31, 2025, $2,151.3 million was unfunded U.S. Government backlog. Close to a third of the number the bull case rests on is work that has been awarded but not yet paid for by a Congress that has to vote on it again.

The filing does not oversell the rest of it either: "Our backlog is subject to unexpected adjustments and cancellations and may not be a reliable indicator of future revenues or earnings". Nor is the contracting structure especially forgiving. Most Government Operations contracts are fixed-price incentive fee arrangements, which means a cost overrun on a first-of-a-kind nuclear component comes out of BWXT's margin rather than the customer's budget. The commercial side carries a parallel policy exposure across the border, where the 10-K warns that project execution issues may lead nuclear plant operators in Canada to delay, curtail or cancel life-extension projects.

Now the price. At today's quote the market is paying roughly 42 times what the business earned in operating income over the trailing year, a multiple that sits at the very top of its peer distribution and well beyond the upper quartile of it. The arithmetic behind that requires today's economics to hold for something like seven years. Of companies that have grown at comparable rates, only around 22% sustained the pace that long. That is not a prediction of failure; it is the base rate, and the price is underwriting the minority case.

What makes the premium harder to defend is that the unit economics are good rather than exceptional. A 12.3% trailing operating margin is a fine number, but LDOS earns 12.0% and NOC 11.6% without anything like this valuation. The gap therefore rests entirely on growth persisting, and growth has increasingly been bought rather than grown: A.O.T. closed in January 2025 and added $52.2 million of revenue in that year, Kinectrics is now contributing to Commercial Operations, and Precision Components Group was announced in the first quarter of 2026. Acquisitive growth raises the hurdle twice, because the acquirer has to integrate the asset and then still earn a return on what it paid.

The balance sheet is not fragile. Operating income covers the interest bill roughly eleven times over, and the share count has been essentially flat across the past four years, so nobody is being diluted to fund this. But a business with real debt, an acquisition pipeline and a valuation at the top of its cohort has used up its margin for error on execution, and the only thing on the other side of that trade is a very long order book that Congress partly has not funded.

Valuation

Work backwards from $174.61 and the assumption is specific. The market is paying about 42 times what the business earns in operating income, and the growth arithmetic behind that number requires the company to hold today's economics for roughly seven years, solved at an 8.5% cost of capital. That calculation is sensitive to its own rate: a single percentage point on the cost of capital shifts the required horizon by about two years, so treat seven as the middle of a band rather than a measurement.

The methods split cleanly. The asset-value approaches and the earnings-power lenses both finish far under the price, at several multiples of distance, and the peer-multiple read puts the price about 90% above where it lands. Only the forward-growth methods reach the quote. That configuration is the signature of a durability premium: the static frames value what has already been demonstrated, and the price is paying for the demonstration continuing.

How the reaching methods get there is worth stating plainly. The cash-flow model that clears the price projects free cash flow growing at 21% a year off a half-billion-dollar base over a seven-year window, and its exit-multiple sibling assumes the enterprise still commands roughly the same EBITDA multiple at the end of that window that it commands now, with the bear scenario compressing only modestly. Neither assumption is unreasonable. Both are assumptions rather than observations, and the price depends on them rather than on the trailing figures.

Cohort position sharpens it. The multiple sits at the very top of the peer distribution, beyond the upper quartile, while the operating margin does not. BWXT's 12.3% compares with 12.0% at LDOS, 11.6% at NOC, 10.2% at GD and 9.9% at LMT. The premium is not paying for better unit economics than the primes deliver. It is paying for a growth rate the primes do not have and for a nuclear franchise that would take a decade and a security clearance to replicate.

Underneath all of it is the backlog, and it deserves to be read with its two halves separated. Of $7,260.7 million at year-end 2025, $2,151.3 million was unfunded U.S. Government work, with roughly 40% of total backlog expected to convert to revenue during 2026. Funded backlog is close to a receivable; unfunded backlog is a legislative expectation. Operating income covers the interest bill about eleven times over, which means the balance sheet is not what decides this. The appropriations calendar is.

Catalysts

The first quarter of 2026, reported May 4, was the strongest print in the recent record and the mix inside it mattered more than the total. Consolidated revenue reached $860.2 million, up 26% from $682.3 million a year earlier, with Government Operations contributing $577.9 million, up 4%, and Commercial Operations $283.6 million, up 121%. GAAP operating income was $106.7 million and GAAP diluted earnings $0.99 a share, both up from the prior year. Free cash flow was $50.1 million against $17.3 million, and dividends paid were $25.8 million.

On the strength of that quarter the company raised its full-year 2026 outlook, lifting its own adjusted EBITDA measure to a range of $650 million to $665 million, its non-GAAP earnings measure to $4.60 to $4.75 a share and its free cash flow measure to $315 million to $330 million. Those are company-defined measures rather than reported results, and the more useful signal is the direction: management raised the number one quarter into the year, citing pacing of work and higher throughput against the existing backlog.

The strategic item from the same release is the acquisition of Precision Components Group, which the company describes as its first step in establishing U.S.-based commercial nuclear component manufacturing capacity. It follows A.O.T., which closed on January 3, 2025 and added $52.2 million of revenue that year, and Kinectrics, now showing up in Commercial Operations results. The pattern is deliberate: BWXT is spending to be the domestic supplier when civilian nuclear construction needs one. Whether that spending earns its cost of capital is the question the next several quarters will start to answer, and the next reading arrives with second-quarter results.

Peer Cohorts (Per Segment, With Filing Citations)

Government Operations (reported)

Commercial Operations (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

BWXT first-quarter 2026 earnings release, May 4, 2026 · BWXT 2025 Form 10-K

View the full interactive BWXT report on boothcheck